novo nordisk a/s-b
(NOVOB:Copenhagen Stock Exchange)
|Age||Total Calculated Compensation||This person is connected to 21 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Kåre Schultz has been the Chief Executive Officer and President of H. Lundbeck A/S since May 20, 2015. Mr. Schultz served as the President and Chief Operating Officer of Novo Nordisk A/S since January 30, 2014 & March 2002 respectively. Mr. Schultz served as Member of Executive Management of Novo Nordisk A/S. Mr. Schultz served as an Executive Vice President of Novo Nordisk A/S from November 2011 to January 2014. He joined Novo Nordisk A/S in 1989 as an Economist ...
Novo AlléPhone: 45 44 44 88 88
Bagsvaerd, Capital Region of Denmark 2880
Fax: 45 44 49 05 55
Board Members Memberships*
Chairman, Chairman of Remuneration Committee and Chairman of Nomination Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marc M.P. de Garidel||Chairman, Chief Executive Officer and Chairman of Strategic Committee|
|Giovanni Recordati||Chairman and Chief Executive Officer|
|Jörg-Thomas Dierks||Chief Executive Officer|
|Vinita Gupta||Chief Executive Officer, Executive Director and Member of Risk Management Committee|
|Timo Lappalainen M.Sc. (Ind. Eng.)||Chairman of the Executive Management Board, Chief Executive Officer and President|
|€1.4M||Compensation as of Fiscal Year 2014.|